📰 Anders Ullman News
Page 6 - Anders Ullman News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Anders Ullman. Real-time updates on events, politics, business and more.
March 9, 2022
Results showed a clinically meaningful prevention of bleeds in people with severe haemophilia A - News - PharmaTimes
March 9, 2022
An experimental hemophilia A therapy from Sanofi and partner Sobi has met the goals of a pivotal study, and the pharmaceutical giant is now planning global regulatory submissions for later this year. The drug could compete against a blockbuster hemophilia A treatment marketed by Roche.
February 2, 2022
STOCKHOLM, Feb. 2, 2022 /PRNewswire/ -- Sobi will present new data at the 15th European Association of Haemophilia and Allied Disorders (EAHAD) virtual conference from 2-4 February 2022, contributing
February 2, 2022
/PRNewswire/ -- Sobi™ will present new data at the 15th European Association of Haemophilia and Allied Disorders (EAHAD) virtual conference from 2-4 February...
February 2, 2022
/PRNewswire/ -- Sobi™ will present new data at the 15th European Association of Haemophilia and Allied Disorders (EAHAD) virtual conference from 2-4 February...
December 13, 2021
/PRNewswire/ -- Anders Ullman, M.D., Ph.D., currently a member of the Board of Directors of Sobi, will become Head of R&D and Chief Medical Officer and replace...